Bone mineral density and bone metabolism in patients with end-stage heart failure awaiting heart transplantation;Knochendichte und Laborparameter des Knochenstoffwechsels bei Patienten mit terminaler Herzerkrankung

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 37, 1996, Pages 1553-1559

  Christ, E ^a,c   Linka, A ^a   Junga, G ^a   Odermatt, M ^a   Steinert, H ^b   Kiowski, W ^a   Schmid, Ch ^a  

^a Kardiologie und Endokrinologie   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; TESTOSTERONE;

ADULT; ARTICLE; BONE DENSITY; BONE DISEASE; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMUR NECK; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LUMBAR SPINE; MALE; RISK ASSESSMENT; X RAY ANALYSIS;

ADULT; AGED; BLOOD CHEMICAL ANALYSIS; BONE AND BONES; BONE DENSITY; DENSITOMETRY, X-RAY; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS;

EID: 0029833991     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dec GW, Semigran MJ, Vlahakes GJ: Cardiac transplantation: current indications and limitations. Transplant Proc 1991; 23: 2095-2106.
2. Kahan BD: Cyclosporine. N Engl J Med 1989; 321: 1725-1738.
3. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK et al.: Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994; 96: 35-11.
4. Shane E, Rivas MDC, Silverberg SJ, Kim TS, Staron RB et al.: Osteoporosis after cardiac transplant. Am J Med 1993; 94: 257-263.
5. Rich GM, Mudge G, LeBoff MS: Cyclosporin A and Prednison-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992; 11: 950-958.
6. Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Int Med 1990; 112: 352-364.
7. Johnston CC, Slemenda CW, Melton LJ: Clinical use of bone densitometry. N Engl J Med 1991; 324: 1105-1109.
8. Wahner HW: Measurements of bone mass and bone density. Endocrinol Metab Clin N Am 1989, 18: 995-1012.
9. Eastell R, Robins SP, Colwell T, Assiri AM, Riggs BL et al.: Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int 1993; 3: 255-260.
10. Seibel M, Zipf A, Ziegler R: Pyridinium-Crosslinks im Urin. Dtsch Med Wochenschr 1994; 119: 923-929.
11. Jones G, Sambrook PN: Drug-induced disorders of bone metabolism. Incidence, management and avoidance. Drug Saf 1994; 10: 480-489.
12. Christiansen C: Prevention and treatment of osteoporosis: a review of current modalities. Bone 1992; 13: 35-39.
13. Kelly TL: Bone mineral density reference databases for American men and women. J Bone Min Res 1990; 5 (Suppl. 2): 249.
14. Katz IA, Epstein S: Posttransplantation bone disease. J Bone Mineral Res 1992; 7: 123-126.
15. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER et al.: Bone disease in liver transplant recepients: incidence, timing, and risk factors. Transplant Proc 1991; 23: 1462-1465.
16. Kelly PJ, Atkinson K, Ward RL, Sambrook PN, Biggs JC et al.: Reduced bone mineral density in men and women with allogeneic bone marrow transplantation. Transplantation 1990; 50: 881-883.
17. Muchmore JS, Cooper DKC, Ye Y, Schlegel VT, Zhudi N: Loss of vertebral bone density in heart transplant patients. Transplant Proc 1991; 23: 1184-1185.
18. Sambrook PN, Kelly PJ, Keogh AM, Macdonald P, Spratt P et al.: Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant 1994; 13: 116-121.